Literature DB >> 23503575

Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer.

Charles Meyer1, Bing Ma, Lakshmi P Kunju, Matthew Davenport, Morand Piert.   

Abstract

Due to poor correlation between slice thickness and orientation, verification of medical imaging results by histology is difficult. Often validation of imaging findings of lesions suspicious for prostate cancer is driven by a subjective, visual approach to correlate in vivo images with histopathology. We describe fallacious assumptions in the correlation of imaging findings with pathology and identify the lack of accurate registration as a major obstacle in the validation of PET and PET/CT imaging in primary prostate cancer. Specific registration techniques that facilitate the most difficult part of the registration process--the mapping of pathology onto high-resolution imaging, preferably aided by the ex vivo prostate specimen--are discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23503575      PMCID: PMC3689866          DOI: 10.1007/s00259-013-2382-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  27 in total

1.  Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers.

Authors:  Corina Udrescu; Patrice Jalade; Berardino de Bari; Géraldine Michel-Amadry; Olivier Chapet
Journal:  Radiother Oncol       Date:  2012-04-20       Impact factor: 6.280

2.  A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.

Authors:  Vijay Shah; Thomas Pohida; Baris Turkbey; Haresh Mani; Maria Merino; Peter A Pinto; Peter Choyke; Marcelino Bernardo
Journal:  Rev Sci Instrum       Date:  2009-10       Impact factor: 1.523

3.  11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.

Authors:  Esther Mena; Baris Turkbey; Haresh Mani; Stephen Adler; Vladimir A Valera; Marcelino Bernardo; Vijay Shah; Thomas Pohida; Yolanda McKinney; Gideon Kwarteng; Dagane Daar; Maria L Lindenberg; Philip Eclarinal; Revia Wade; W Marston Linehan; Maria J Merino; Peter A Pinto; Peter L Choyke; Karen A Kurdziel
Journal:  J Nucl Med       Date:  2012-02-17       Impact factor: 10.057

4.  Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.

Authors:  Hari Trivedi; Baris Turkbey; Ardeshir R Rastinehad; Compton J Benjamin; Marcelino Bernardo; Thomas Pohida; Vijay Shah; Maria J Merino; Bradford J Wood; W Marston Linehan; Aradhana M Venkatesan; Peter L Choyke; Peter A Pinto
Journal:  Urology       Date:  2012-01       Impact factor: 2.649

5.  High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique.

Authors:  Xiaobing Fan; Chad R Haney; Garima Agrawal; Charles A Pelizzari; Tatjana Antic; Scott E Eggener; Ila Sethi; Jonathan N River; Marta Zamora; Gregory S Karczmar; Aytekin Oto
Journal:  J Magn Reson Imaging       Date:  2011-10       Impact factor: 4.813

6.  PET/CT and choline: diagnosis and staging.

Authors:  M Farsad; S Schwarzenböck; B J Krause
Journal:  Q J Nucl Med Mol Imaging       Date:  2012-08       Impact factor: 2.346

7.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Authors:  Anna Bill-Axelson; Lars Holmberg; Frej Filén; Mirja Ruutu; Hans Garmo; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

8.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers.

Authors:  J M Balter; H M Sandler; K Lam; R L Bree; A S Lichter; R K ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-01-01       Impact factor: 7.038

9.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

10.  Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.

Authors:  Ji Chen; Yong Zhao; Xin Li; Peng Sun; Muwen Wang; Ridong Wang; Xunbo Jin
Journal:  Radiol Oncol       Date:  2012-06-19       Impact factor: 2.991

View more
  18 in total

1.  A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.

Authors:  Alan Priester; Shyam Natarajan; Jesse D Le; James Garritano; Bryan Radosavcev; Warren Grundfest; Daniel Ja Margolis; Leonard S Marks; Jiaoti Huang
Journal:  Am J Clin Exp Urol       Date:  2014-07-12

2.  Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).

Authors:  Ivan Jambor; Anna Kuisma; Esa Kähkönen; Jukka Kemppainen; Harri Merisaari; Olli Eskola; Jarmo Teuho; Ileana Montoya Perez; Marko Pesola; Hannu J Aronen; Peter J Boström; Pekka Taimen; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-16       Impact factor: 9.236

3.  Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.

Authors:  Alan Priester; Shyam Natarajan; Pooria Khoshnoodi; Daniel J Margolis; Steven S Raman; Robert E Reiter; Jiaoti Huang; Warren Grundfest; Leonard S Marks
Journal:  J Urol       Date:  2016-07-30       Impact factor: 7.450

4.  18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.

Authors:  Morand Piert; Jeffrey Montgomery; Lakshmi Priya Kunju; Javed Siddiqui; Virginia Rogers; Thekkelnaycke Rajendiran; Timothy D Johnson; Xia Shao; Matthew S Davenport
Journal:  J Nucl Med       Date:  2016-03-16       Impact factor: 10.057

5.  Preclinical Evaluation of 11C-Sarcosine as a Substrate of Proton-Coupled Amino Acid Transporters and First Human Application in Prostate Cancer.

Authors:  Morand Piert; Xia Shao; David Raffel; Mathew S Davenport; Jeffrey Montgomery; Lakshmi Priya Kunju; Brian G Hockley; Javed Siddiqui; Peter J H Scott; Arul M Chinnaiyan; Thekkelnaycke Rajendiran
Journal:  J Nucl Med       Date:  2017-03-16       Impact factor: 10.057

Review 6.  Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.

Authors:  Lizhi Liu; Zhiqiang Tian; Zhenfeng Zhang; Baowei Fei
Journal:  Acad Radiol       Date:  2016-04-25       Impact factor: 3.173

Review 7.  Mass Spectrometry Imaging: A Review of Emerging Advancements and Future Insights.

Authors:  Amanda Rae Buchberger; Kellen DeLaney; Jillian Johnson; Lingjun Li
Journal:  Anal Chem       Date:  2017-12-13       Impact factor: 6.986

Review 8.  Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence.

Authors:  Jason Bailey; Morand Piert
Journal:  Curr Urol Rep       Date:  2017-09-09       Impact factor: 3.092

9.  Registration Accuracy of Patient-Specific, Three-Dimensional-Printed Prostate Molds for Correlating Pathology With Magnetic Resonance Imaging.

Authors:  Alan Priester; Holden Wu; Pooria Khoshnoodi; Douglas Schneider; Zhaohuan Zhang; Nazanin H Asvadi; Anthony Sisk; Steven Raman; Robert Reiter; Warren Grundfest; Leonard S Marks; Shyam Natarajan
Journal:  IEEE Trans Biomed Eng       Date:  2018-04-19       Impact factor: 4.538

10.  Registration of histopathology to magnetic resonance imaging of prostate cancer.

Authors:  Kristina Sandgren; Erik Nilsson; Angsana Keeratijarut Lindberg; Sara Strandberg; Lennart Blomqvist; Anders Bergh; Bengt Friedrich; Jan Axelsson; Margareta Ögren; Mattias Ögren; Anders Widmark; Camilla Thellenberg Karlsson; Karin Söderkvist; Katrine Riklund; Joakim Jonsson; Tufve Nyholm
Journal:  Phys Imaging Radiat Oncol       Date:  2021-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.